201 related articles for article (PubMed ID: 38103343)
1. Cold atmospheric plasma sensitizes head and neck cancer to chemotherapy and immune checkpoint blockade therapy.
Wang Y; Mang X; Li D; Wang Z; Chen Y; Cai Z; Tan F
Redox Biol; 2024 Feb; 69():102991. PubMed ID: 38103343
[TBL] [Abstract][Full Text] [Related]
2. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway.
Wang Y; Mang X; Li D; Chen Y; Cai Z; Tan F
Free Radic Biol Med; 2023 Nov; 208():134-152. PubMed ID: 37543168
[TBL] [Abstract][Full Text] [Related]
3. Cold atmospheric plasma induces apoptosis in human colon and lung cancer cells through modulating mitochondrial pathway.
Wang Y; Mang X; Li X; Cai Z; Tan F
Front Cell Dev Biol; 2022; 10():915785. PubMed ID: 35959493
[TBL] [Abstract][Full Text] [Related]
4. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
5. Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in-vitro study.
Brunner TF; Probst FA; Troeltzsch M; Schwenk-Zieger S; Zimmermann JL; Morfill G; Becker S; Harréus U; Welz C
Head Face Med; 2022 Jun; 18(1):21. PubMed ID: 35768853
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials.
Huang Z; Zheng S; Ding S; Wei Y; Chen C; Liu X; Li H; Xia Y
J Cancer Res Ther; 2021 Jul; 17(3):676-687. PubMed ID: 34269299
[TBL] [Abstract][Full Text] [Related]
7. Open Questions in Cold Atmospheric Plasma Treatment in Head and Neck Cancer: A Systematic Review.
Perrotti V; Caponio VCA; Muzio LL; Choi EH; Di Marcantonio MC; Mazzone M; Kaushik NK; Mincione G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142145
[TBL] [Abstract][Full Text] [Related]
8. Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.
Bai X; Wang X; Ma G; Song J; Liu X; Wu X; Zhao Y; Liu X; Liu Z; Zhang W; Zhao X; Zheng Z; Jing J; Shi H
Front Immunol; 2021; 12():793831. PubMed ID: 34987517
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome.
Röhl L; Wellhausen J; Berszin M; Krücken I; Zebralla V; Pirlich M; Wiegand S; Dietz A; Wald T; Wichmann G
Front Immunol; 2023; 14():1237623. PubMed ID: 37849764
[TBL] [Abstract][Full Text] [Related]
10. Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment.
Fang T; Cao X; Shen B; Chen Z; Chen G
Biomaterials; 2023 Sep; 300():122189. PubMed ID: 37307777
[TBL] [Abstract][Full Text] [Related]
11. Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide.
Tseng JC; Yang JX; Liu YL; Su YW; Lee AY; Chen YW; Liu KJ; Luo Y; Hong YR; Chuang TH
Cancer Immunol Immunother; 2022 May; 71(5):1115-1128. PubMed ID: 34581869
[TBL] [Abstract][Full Text] [Related]
12. Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
Guo B; Pomicter AD; Li F; Bhatt S; Chen C; Li W; Qi M; Huang C; Deininger MW; Kong MG; Chen HL
Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34916286
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
14. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.
Marquard FE; Jücker M
Biochem Pharmacol; 2020 Feb; 172():113729. PubMed ID: 31785230
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380
[TBL] [Abstract][Full Text] [Related]
17. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
Yang H; Li H; Lu S; Shan S; Guo Y
Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
[TBL] [Abstract][Full Text] [Related]
18. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
19. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
[TBL] [Abstract][Full Text] [Related]
20. Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer: Biomarkers of Response and Resistance.
Maroun CA; Mandal R
Otolaryngol Clin North Am; 2021 Aug; 54(4):751-759. PubMed ID: 34116842
[No Abstract] [Full Text] [Related]
[Next] [New Search]